Cell line name NCC-ssRMS2-C1
Accession CVCL_A0BR
Resource Identification Initiative To cite this cell line use: NCC-ssRMS2-C1 (RRID:CVCL_A0BR)
Comments Part of: NCC sarcoma cell line panel.
Population: Japanese.
Doubling time: ~41 hours (PubMed=34164773).
Omics: SNP array analysis.
Misspelling: NCC-ssRMS1-C2; Note=In Cellosaurus release 39.
Derived from site: In situ; Back; UBERON=UBERON_0001137.
Sequence variations
Mutation; HGNC; 7611; MYOD1; None_reported; -; Zygosity=- (PubMed=34164773).
Disease Spindle cell/sclerosing rhabdomyosarcoma (NCIt: C121654)
Rhabdomyosarcoma (ORDO: Orphanet_780)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Sex of cell Male
Age at sampling 40Y
Category Cancer cell line
STR profile

Source(s): PubMed=34164773


Amelogenin X,Y
CSF1PO 11,13
D5S818 10,11
D7S820 11
D13S317 11
D16S539 9,11
D21S11 30,32.2
TH01 9
TPOX 8,11
vWA 14,17

PubMed=34164773; DOI=10.1007/s13577-021-00569-1
Tsuchiya R., Yoshimatsu Y., Noguchi R., Sin Y., Ono T., Sei A., Takeshita F., Sugaya J., Nakatani F., Yoshida A., Ohtori S., Kawai A., Kondo T.
Establishment and characterization of NCC-ssRMS2-C1: a novel patient-derived cell line of spindle cell/sclerosing rhabdomyosarcoma.
Hum. Cell 34:1569-1578(2021)

Encyclopedic resources Wikidata; Q108821015

Additional information

User Category

Academia/non-profit organization, For-profit organization


There are no reviews yet.

Be the first to review “NCC-ssRMS2-C1”

Your email address will not be published. Required fields are marked *